Understanding Chronic Lymphocytic Leukemia
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 2,750
- 试验地点
- 2
- 主要终点
- Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia
研究概览
简要总结
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
详细描述
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia, for the potential development of more effective therapies for this disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
- •Any low grade lymphoproliferative disorder
- •Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere
排除标准
- 未提供
研究组 & 干预措施
Sample Collection
- Blood tests required for assessment
- Specimens and data will also be collected from outside sites
- Clinical data from patients with Chronic Lymphocytic Leukemia will be gathered into a database at Dana Farber Cancer Institute
结局指标
主要结局
Incidence of novel genomic prognostic markers in Chronic Lymphocytic Leukemia
时间窗: 20 years
Exploratory science to better understand Chronic Lymphocytic Leukemia
次要结局
未报告次要终点
研究者
Jennifer R. Brown, MD, PhD
Principal Investigator
Dana-Farber Cancer Institute
